Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
per week
for 24 weeks
// //

Inovio Pharma NASDAQ: INO-Q

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 8.33
Day High 8.58
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.



A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021
- PR Newswire - PRF - Mon Jul 26, 7:00AM CDT
PR Newswire - PRF - CMTX
Mon Jul 26, 7:00AM CDT
/PRNewswire/ -- INOVIO (NASDAQ: INO) announced today that second quarter 2021 financial results will be released after the market close on . Following the release, INOVIO will host a live conference call and webcast at to discuss financial results and provide a general business update regarding its DNA Medicines Platform, including the company's ongoing vaccine developments for COVID-19.
USD 104.87 Billion, Vaccines Industry Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Report [2027]
- GlobeNewswire - Wed Jun 30, 4:11AM CDT
GlobeNewswire - CMTX
Wed Jun 30, 4:11AM CDT
The global business Vaccines Industry share is projected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7 % during the forecast period due to rise in infectious diseases observes, Fortune Business Insights(TM) in a published report, titled, "Vaccines Industry, 2020-2027."
Thinking about buying stock in Sellas Life Sciences, ContextLogic, Corsair Gaming, Inovio Pharmaceuticals, or The GEO Group?
- PR Newswire - PRF - Thu Jun 10, 8:31AM CDT
PR Newswire - PRF - CMTX
Thu Jun 10, 8:31AM CDT
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SLS, WISH, CRSR, INO, and GEO.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 7.68 +9.37% increase
on 07/15/21
Period Open:9.27
Price movement based on the high, low and last over the given period.
9.51 -11.67% decrease
on 07/02/21
-0.87 (-9.39%) decrease
since 06/30/21
3-Month 5.81 +44.58% increase
on 05/11/21
Period Open:6.81
Price movement based on the high, low and last over the given period.
10.33 -18.68% decrease
on 06/09/21
+1.59 (+23.35%) increase
since 04/30/21
52-Week 5.81 +44.58% increase
on 05/11/21
Period Open:20.73
Price movement based on the high, low and last over the given period.
22.13 -62.04% decrease
on 08/05/20
-12.33 (-59.48%) decrease
since 07/30/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies